Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
Clinical trial NCT05186974 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05186974
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2026-09-01
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.